The next-generation sequencing (NGS) data analysis market is projected to reach $4.21b by 2032 at a compound annual growth rate of approximately 20%, according to SNS Insider pvt ltd.

Appistry is a scientific software company that bridges the gap between genomics data and health outcomes by making next-generation sequencing data analysis more approachable and actionable to ...

An overview of bioinformatics and where it fits into NGS workflows–including target enrichment; A walk-through of the analysis stages of Roche’s bioinformatics container solution for target-enriched ...

But, as with any great methodology shift, several challenges impede its widespread implementation. From cancer complexities such as tumor heterogeneity to bottlenecks in next-generation sequencing ...

Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems MOUNTAIN VIEW, Calif. & SOUTH ...

Next-generation sequencing (NGS) has revolutionized oncology diagnostics. However, the interpretation of complex genomic data has become a critical bottleneck in clinical workflows. Manual data ...

In this episode, supported by Zymo Research (CA, USA), guest host Georgia Bickerton explores next-generation sequencing (NGS) data and how bioinformatic pipelines and workflows can be optimized to ...